CANDRIAM S.C.A. – Cogent Biosciences, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$17.18M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+65.41%
quarter
Cogent Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.95% | -99.38K shares | 5.89M | $14.92 | 1.15M |
| Q2 2022 | share | Decrease | -28.64% | -502.09K shares | -1.84M | $9.02 | 1.25M |
| Q1 2022 | share | Decrease | -6.05% | -112.79K shares | -2.87M | $7.49 | 1.75M |
| Q4 2021 | share | Decrease | -3.19% | -61.47K shares | -199K | $8.56 | 1.86M |
| Q3 2021 | share | Increase | +0.87% | 16.52K shares | 711K | $8.41 | 1.92M |
| Q2 2021 | share | Increase | +302.42% | 1.43M shares | 10.37M | $8.11 | 1.91M |
| Q1 2021 | share | Increase | +0.02% | 108 shares | -209K | $8.78 | 474.80K |
| Q4 2020 | share | Increase | 0.00% | 474.70K shares | 5.33M | $11.23 | 474.70K |